A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Ozempic and Wegovy, made by Novo Nordisk (NVO), traditionally have been used to treat patients with type 2 diabetes, though they have gained notoriety as weight loss drugs. Research published by ...

A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three ...

Drugs like Ozempic and Mounjaro are becoming increasingly popular for treating obesity and type 2 diabetes. These medications ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently approved only for type 2 diabetes, according to results from a small trial.

The authors said in summary: “In people with type 2 diabetes, tirzepatide 5mg, 10mg, and 15mg were more efficacious in reducing HbA1c compared to semaglutide 0.5mg, 1.0mg, and 2.0mg, respectively.

Semaglutide medications such as Ozempic can significantly reduce the risk of kidney complications, heart issues and death in people with Type 2 diabetes, according to a study published Friday ...